Emral R, et al. – This study quantifies hypoglycemia incidence in insulin–treated patients with diabetes. These outcomes represent the first patient–reported dataset on hypoglycemia in the participating countries and validate that hypoglycemia is under–reported and more widespread than previously believed. While the incidence of hypoglycemia was variable among patients on different treatment regimens, there were substantial effects on both productivity and healthcare utilization following an episode of hypoglycemia.

Methods

• In this International Operations HAT (IO HAT) study, researchers retrospectively and prospectively examined the incidence of hypoglycemia in patients with insulin–treated diabetes in Bangladesh, Colombia, Egypt, Indonesia, Philippines, Singapore, South Africa, Turkey, and United Arab Emirates.

Results

• They noted hypoglycemic events by 97.4% of patients with type 1 diabetes and 95.3% of those with type 2 diabetes, with an estimated rate of 6.86 events per patient per month (PPPM) for patients with type 1 diabetes and 2.37 events PPPM for patients with type 2 diabetes during the prospective period.